SCHOTT PHARMA INH O.N./ DE000A3ENQ51 /
2024-06-03 9:30:36 AM | Chg. -0.3800 | Volume | Bid5:35:40 PM | Ask5:42:00 PM | High | Low |
---|---|---|---|---|---|---|
28.9000EUR | -1.30% | 104 Turnover: 3,161.6000 |
28.8600Bid Size: 200 | 29.3000Ask Size: 200 | 30.4600 | 28.9000 |
GlobeNewswire
5:53 PM
Sustainable Green Team, Ltd. (SGTM) Signs Purchase Agreement to Acquire Patents and Intellectual Pro...
GlobeNewswire
5:35 PM
Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases
GlobeNewswire
5:33 PM
Natiivo Hospitality Expands with New South Florida Projects, Hires Yoav Gery as President
GlobeNewswire
5:30 PM
Titan.ium Platform Announces Collaboration with Nokia Improving Security for Global Telecommunicatio...
GlobeNewswire
5:20 PM
New CryptoStaking Strategies Introduced by CryptoHeap to Maximize Investor Returns
GlobeNewswire
5:15 PM
DEADLINE ALERT for HRT and CKPT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions...
GlobeNewswire
5:13 PM
Los Angeles Student Wins NFTE West (Southern California) Youth Entrepreneurship Challenge
GlobeNewswire
5:12 PM
Kirby McInerney LLP Reminds Harbor Diversified, Inc. (HRBR) Investors of Class Action Filing and Enc...
GlobeNewswire
5:11 PM
Kirby McInerney LLP Reminds Global Cord Blood Corporation (CORBF) Investors of Upcoming Deadline in ...
GlobeNewswire
5:11 PM
Infuse Summer Fun In Your Coffee With Bones Coffee Company’s New, Limited-Edition Summer Flavors
GlobeNewswire
5:02 PM
Cambria Investment Management and Chesapeake Capital Corporation Announces the Launch of the Cambria...
GlobeNewswire
5:00 PM
MidWestOne Financial Group Welcomes Three Key Executive Leaders to the Organization
GlobeNewswire
5:00 PM
Zevra Therapeutics Announces Positive Final Results from Phase 2 Clinical Trial of KP1077 for Idiopa...